Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guidance and tools
Guidance and tools
Choosing investments Choosing accounts ISA calculator Retirement calculators
Shares
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
Broker tips: THG, Liontrust, Rentokil Initial, Cerillion
(Sharecast News) - Citi resumed coverage of e-commerce group THG on Thursday with a 'buy' rating and 220.0p price target. The bank said that amid M&A news flow, commodities and forex-driven downgrades, corporate governance debates, and questions over THG Ingenuity, the market seems to be underestimating the value of the beauty division.
It said Beauty was "a very strong player" in "a very attractive market" and could make up for the total valuation of the company on its own.
Numis initiated coverage of international distribution and services firm Bunzl on Thursday with a 'hold' rating.
The broker, which has a target price of 2,600.0p, said the stock was likely to be supported by Bunzl's track record in mergers and acquisitions.
It noted: "In a period of elevated economic uncertainty, Bunzl's defensive growth attributes should support relative share price resilience. Long-term organic growth is lower than other listed distributors, but Bunzl's track record of acquisitions has still driven shareholder value and we would expect this to continue.
"With leverage currently below the group's target range, we see scope for up to 20% update to our earnings per share estimates over three years from M&A."
Analysts at Berenberg slashed their target price on asset manager Liontrust from 1,850.0p to 1,100.0p despite the group's full-year results beating expectations, stating falling markets looked set to weigh on the stock.
Berenberg said Liontrust's recently wrapped up trading year was characterised by a "strong" level of earnings growth but noted that this had been offset by falling markets since the start of the calendar year.
"The company reported strong FY22 results with EPS of 127.6p (up by 59% yoy), c13% ahead of consensus expectations. Liontrust demonstrated strong organic assets under management and administration (AUMA) growth of £2.5bn in FY22, representing a c8% annualised organic growth rate," said Berenberg.
"That said, total AUMA fell by c12% to £34.2bn between 1 April and 17 June as a result of negative market movements driven by the conflict in Ukraine. Organic growth has actually gone into reverse since the beginning of FY23; this is understandable in light of the higher levels of uncertainty in the first part of the year and Liontrust's predominantly UK retail footprint."
Taking this into account, the German bank cut its full-year 2023-24 estimates by roughly 8-17% to reflect the current market levels but opted to reiterate its 'hold' rating on the stock.
Deutsche Bank upgraded Rentokil Initial on Thursday to 'buy' from 'hold' as it highlighted the potential for a resilient performance and benefits from the Terminix acquisition.
It said the wider pest control industry has experienced consistent growth through the cycle in the USA, with no year of nominal revenue decline since 1988, and only four in real terms.
"We believe this should result in a resilient performance in the event of weakening economy," DB said, adding that industry data indicates prices are rising to offset costs.
DB also said the Terminix deal has the potential to be significantly value-enhancing.
"The recent SEC filing indicated that Terminix's own internal projections are substantially higher than market forecasts for 2023+ and they assume $175.0m synergies are possible," the bank said.
Deutsche left its price target on Rentokil shares unchanged at 550.0p.
Analysts at Canaccord Genuity hiked their target price on software Cerillion from 950.0p to 1,100.0p on Thursday as they raised their estimates for the group and labelled expectations as "conservative".
Canaccord Genutiy said Cerillion's recent interim results showed an "encouraging" growth in organic sales of about 25% and temporarily elevated underlying earnings margins of 39%, with some normalisation likely in the second half of the year due to salary inflation.
The Canadian bank stated backlog was slightly down year-on-year and sequentially due to the timing of larger deal signings, which the company expects to accelerate in the second half. It also noted that new customer momentum was "strong", with the new logo sales pipeline up 31% year-on-year at £172.0m.
"We have raised our revenue, EBIT & EPS forecasts with our/consensus estimates implying a 67:33 1H:2H EBIT split - this seems conservative compared to the 45:55 historical average and in our view implies scope for upside," said Canaccord.
"The shares' current ~29x cal. '23 P/E is broadly inline with UK peers such as Aptitude, Netcall and Alfa FS despite superior top line and EPS growth. Our new target is based on a cal. 2023 P/E of 34x, a 25% premium to listed peers due to its superior growth and higher margins."
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Award-winning online share dealing
Search, compare and select from thousands of shares.
Expert insights into investing your money
Our team of experts explore the world of share dealing.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity, Equity & Inclusion | Doing Business with Fidelity | Diversity, Equity & Inclusion Reports | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Staying secure | Statutory and Regulatory disclosures | Whistleblowing programme
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.